Today: 29 April 2026
IDBI Bank shares rally again as privatisation bid deadline hits; analyst flags ₹130 target
5 February 2026
1 min read

IDBI Bank shares rally again as privatisation bid deadline hits; analyst flags ₹130 target

Mumbai, Feb 5, 2026, 11:29 IST

IDBI Bank shares pushed higher Thursday, hitting a peak of 113.50 rupees before pulling back slightly to trade around 111.57 rupees by 10:30 a.m., up about 2%. This came despite the Nifty 50 falling 0.5%. The stock has climbed nearly 13% this February, boosted by the Union Budget’s 80,000-crore-rupee (800 billion rupees) disinvestment target. Drumil Vithlani, a technical analyst at Bonanza, noted that breaking above 110 rupees “can further accelerate upside momentum,” eyeing a range of 125–130 rupees. Business Standard

The rally shifts focus onto a long-awaited sale New Delhi has framed as a key test of its push to trim state holdings and attract private investors. For traders, it’s a straightforward calendar play: deadlines draw eyes, even if the results remain uncertain.

India’s federal government has set a Feb. 5 deadline for financial bids for IDBI Bank, two sources told Reuters, signaling the sale is nearing its final phase. The Reserve Bank of India approved Fairfax Financial Holdings, Emirates NBD, and Kotak Mahindra Bank as eligible bidders for 2024. According to the report, the government alongside state-owned Life Insurance Corporation of India aims to offload 60.7% of the lender.

The stock jumped 10% on Wednesday on the BSE, with average volumes soaring more than fourfold, and around 41.5 million shares traded across the NSE and BSE, according to Business Standard. As of Dec. 31, 2025, LIC owned 49.24% of IDBI Bank, while the government held 45.48%, together controlling 94.71%. The lender said that the strategic stake sale is being managed by the Department of Investment and Public Asset Management (DIPAM). Business Standard also referenced ICRA’s September 2025 rating note, which pointed to recoveries from legacy stressed assets as a key factor boosting profitability and shoring up capital buffers.

Employee unions have pushed to make the sale politically costly. They requested meetings with the Prime Minister and Finance Minister, urging the Centre to rethink selling to private or foreign buyers, BusinessLine reported.

“Strategic disinvestment” is just a softer way of saying selling a major stake plus management control, not merely cutting back on shares. In bank deals, this typically triggers extra regulator scrutiny, tougher conditions, and plenty of chances for deadlines to drag out.

IDBI appeals as a lender that’s left behind its worst bad-loan phase, yet remains burdened by heavy state and insurer ownership. Any buyer would gain access to its branch network and deposits but must also contend with the political sensitivities tied to the sale.

The mix of bidders, featuring both a domestic private lender and a foreign bank, complicates matters. Cross-border banking transactions often trigger stricter scrutiny on governance, capital requirements, and control issues, even if the financials appear straightforward.

Still, the process risks stumbling if bidders shy away from the price, regulators push for adjustments, or staff opposition grows stronger as the handover nears. Following a strong stock surge, even a slight delay or letdown on bids could quickly sour sentiment.

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:58 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Northern Star shares tumble 4.6% as gold slips again — what investors watch before Feb 12 results
Previous Story

Northern Star shares tumble 4.6% as gold slips again — what investors watch before Feb 12 results

Evolution Mining share price slides after gold rout; what to watch before next week’s results
Next Story

Evolution Mining share price slides after gold rout; what to watch before next week’s results

Go toTop